Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease - Sarepta Therapeutics

Sarepta Therapeutics - Feb 04, 2026

ING Groep NV Has $4.64 Million Stock Holdings in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

MarketBeat - Feb 13, 2026

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance

Yahoo Finance - Feb 11, 2026

Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up - BioSpace

BioSpace - Feb 05, 2026

Principal Financial Group Inc. Acquires 244,181 Shares of Sarepta Therapeutics, Inc. $SRPT - MarketBeat

MarketBeat - Feb 13, 2026

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

Sarepta Therapeutics - Nov 03, 2025

Following Sarepta Woes, Others Look To Unlock the Next Chapter in DMD Treatment - BioSpace

BioSpace - Feb 09, 2026

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Dec 18, 2025

New York State Common Retirement Fund Has $703,000 Position in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

MarketBeat - Feb 11, 2026

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label - Sarepta Therapeutics

Sarepta Therapeutics - Jul 16, 2025

Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Dec 03, 2025

Sarepta Therapeutics Applauds Addition of Duchenne Muscular Dystrophy to the U.S. Recommended Uniform Screening Panel (RUSP) - Sarepta Therapeutics

Sarepta Therapeutics - Dec 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment